#152928

Anti-SV40T [Pab 430]

Cat. #152928

Anti-SV40T [Pab 430]

Cat. #: 152928

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 1-2 weeks

Target: Simian virus (SV40) T antigen (large T and small T antigen)

Class: Monoclonal

Application: IP ; RIA ; WB

Reactivity: Virus

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Lionel Crawford

Institute: Cancer Research UK, London Research Institute: Clare Hall Laboratories

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-SV40T [Pab 430]
  • Clone: Pab 430
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Virus
  • Host: Mouse
  • Application: IP ; RIA ; WB
  • Description: SV40 is a simian oncogenic polyoma virus. The SV40 large T antigen is an early protein that interacts with the p53 and Rb tumour suppressor proteins.
  • Immunogen: SV40 transformed mouse cells
  • Isotype: IgG3

Target Details

  • Target: Simian virus (SV40) T antigen (large T and small T antigen)
  • Target background: SV40 is a simian oncogenic polyoma virus. The SV40 large T antigen is an early protein that interacts with the p53 and Rb tumour suppressor proteins.

Applications

  • Application: IP ; RIA ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Kennedy et al. 1985. J Exp Med. 161(6):1432-49. PMID: 2409201.
  • Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies.
  • Harlow et al. 1981. J Virol. 39(3):861-9. PMID: 6169844.
  • Monoclonal antibodies specific for simian virus 40 tumor antigens.